Bath & Body Works, Inc. (NYSE:BBWI) delivered first-quarter earnings that beat analyst forecasts, with revenue hitting the upper end of its guidance, although the stock dipped about 1.3% following the report.
For the quarter ending May 3, 2025, the home fragrance and personal care retailer posted adjusted earnings per share of $0.49, exceeding the consensus estimate of $0.42. This marks a 29% jump from $0.38 in the same period last year. Revenue grew 2.9% year-over-year to $1.4 billion, aligning with the top range of company guidance but slightly below the $1.42 billion consensus.
Bath & Body Works confirmed its full-year 2025 outlook, forecasting net sales growth between 1% and 3% compared to fiscal 2024, alongside earnings per diluted share expected between $3.25 and $3.60. This forecast accounts for current tariff levels and roughly $300 million in planned share buybacks.
“Our team delivered a strong start to the year driven by the positive customer response to our innovation in the quarter,” said Eva Boratto, CFO of Bath & Body Works. “We’re effectively leveraging our predominantly U.S.-based supply chain to navigate the evolving trade environment.”
Looking ahead to Q2 2025, the company projects net sales to be flat to up 2% year-over-year, with EPS estimates ranging from $0.33 to $0.38.
Last week, Bath & Body Works named Daniel Heaf as its new CEO, effective May 16, 2025. Heaf expressed confidence in the company’s future, stating he is poised to “define and lead the home fragrance and beauty categories globally and accelerate growth.”